Li Yi, Xiao Ming, Guo Fangchun
1 Department of Gynecology, The Second People's Hospital of Liaocheng City, Linqing, P.R. China.
2 Department of Cardiology, The Second People's Hospital of Liaocheng City, Linqing, P.R. China.
Tumour Biol. 2017 May;39(5):1010428317705508. doi: 10.1177/1010428317705508.
SOX6 plays important roles in cell proliferation, differentiation, and cell fate determination. It has been confirmed that SOX6 is a tumor suppressor and downregulated in various cancers, including esophageal squamous cell carcinoma, hepatocellular carcinoma, and chronic myeloid leukemia. Netrin-1 is highly expressed in various human cancers and acts as an anti-apoptotic and proangiogenic factor to drive tumorigenesis. The role of SOX6 and netrin-1 in regulating the growth of ovarian tumor cells still remains unclear. Real-time polymerase chain reaction and western blot were used to determine the SOX6 messenger RNA and protein levels, respectively, in ovarian cancer cells and tumor tissues. Stable transfection of SOX6 was conducted to overexpress SOX6 in PA-1 and SW626 cells. Cell viability was measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Invasion of ovarian cancer cells and migration of human umbilical vein endothelial cells were confirmed by Transwell assays. To overexpress netrin-1, ovarian cancer cells with SOX6 restoration was transduced with netrin-1 lentiviral particles. PA-1 xenografts in a nude mice model were used to conduct in vivo evaluation of the role of SOX6 and its relationship with netrin-1 in tumor growth and angiogenesis. In this study, we found significantly reduced SOX6 levels in PA-1, SW626, SK-OV-3, and CaoV-3 ovarian cancer cell lines and human tumor tissues in comparison with normal human ovarian epithelial cells or matched non-tumor tissues. SOX6 overexpression by stable transfection dramatically inhibited proliferation and invasion of PA-1 and SW626 cells. Also, conditioned medium from PA-1 and SW626 cells with SOX6 restoration exhibited reduced ability to induce human umbilical vein endothelial cells migration and tube formation compared with conditioned medium from the cells with transfection control. Furthermore, an inverse relationship between SOX6 and netrin-1 expression was observed in PA-1 and SW626 cells. Overexpression of netrin-1 in ovarian cancer cells with forced SOX6 expression remarkably abrogated the inhibitory effect of SOX6 on proliferation, invasion of the cells, and tumor xenograft growth and vascularity in vivo. Human umbilical vein endothelial cell migration and tube formation were enhanced in the conditioned medium from the ovarian cancer cells transduced with netrin-1 lentivirus particles. Our observations revealed that SOX6 is a tumor suppressor in ovarian cancer cells, and SOX6 exerts an inhibitory effect on the proliferation, invasion, and tumor cell-induced angiogenesis of ovarian cancer cells, whereas nerin-1 plays an opposite role and its expression is inversely correlated with SOX6. Moreover, our findings suggest a new role of SOX6 and netrin-1 for understanding the progression of ovarian cancer and have the potential for the development of new diagnosis and treatment strategies for ovarian cancer.
SOX6在细胞增殖、分化及细胞命运决定过程中发挥着重要作用。现已证实,SOX6是一种肿瘤抑制因子,在包括食管鳞状细胞癌、肝细胞癌及慢性髓性白血病在内的多种癌症中表达下调。Netrin-1在多种人类癌症中高表达,作为一种抗凋亡和促血管生成因子推动肿瘤发生。SOX6和Netrin-1在调控卵巢肿瘤细胞生长中的作用仍不清楚。采用实时聚合酶链反应和蛋白质印迹法分别检测卵巢癌细胞和肿瘤组织中SOX6信使核糖核酸及蛋白水平。通过稳定转染SOX6使PA-1和SW626细胞中SOX6过表达。采用3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐法检测细胞活力。通过Transwell实验检测卵巢癌细胞侵袭及人脐静脉内皮细胞迁移情况。为使Netrin-1过表达,用Netrin-1慢病毒颗粒转导恢复SOX6表达的卵巢癌细胞。利用裸鼠模型中的PA-1异种移植瘤对SOX6的作用及其与Netrin-1在肿瘤生长和血管生成中的关系进行体内评估。在本研究中,我们发现与正常人类卵巢上皮细胞或配对的非肿瘤组织相比,PA-1、SW626、SK-OV-3和CaoV-3卵巢癌细胞系及人类肿瘤组织中SOX6水平显著降低。通过稳定转染使SOX6过表达可显著抑制PA-1和SW626细胞的增殖和侵袭。此外,与转染对照细胞的条件培养基相比,恢复SOX6表达的PA-1和SW626细胞的条件培养基诱导人脐静脉内皮细胞迁移和形成管样结构的能力降低。此外,在PA-1和SW626细胞中观察到SOX6与Netrin-1表达呈负相关。在强制表达SOX6的卵巢癌细胞中过表达Netrin-1可显著消除SOX6对细胞增殖、侵袭及体内肿瘤异种移植生长和血管形成的抑制作用。用Netrin-1慢病毒颗粒转导的卵巢癌细胞的条件培养基可增强人脐静脉内皮细胞迁移和形成管样结构的能力。我们的观察结果表明,SOX6是卵巢癌细胞中的一种肿瘤抑制因子,对卵巢癌细胞的增殖、侵袭及肿瘤细胞诱导的血管生成发挥抑制作用,而Netrin-1则发挥相反作用,其表达与SOX6呈负相关。此外,我们的研究结果提示了SOX6和Netrin-1在理解卵巢癌进展方面的新作用,具有开发卵巢癌新诊断和治疗策略的潜力。